Literature DB >> 34228282

Synthetic Receptors for Sensing Soluble Molecules with Mammalian Cells.

Leo Scheller1.   

Abstract

Synthetic receptors control cell behavior in response to environmental stimuli for applications in basic research and cell therapy. However, the integration of synthetic receptors in unexplored contexts is cumbersome, especially for nonspecialist laboratories. Here, I provide a detailed protocol on how to use receptors of the generalized extracellular molecule sensor (GEMS) platform. GEMS is a modular receptor system that can be adapted to sense molecules of choice by using affinity domains that dimerize in response to the target. GEMS consist of an erythropoietin receptor scaffold that has been mutated to no longer bind to erythropoietin. N-terminal fusions with affinity domains, such as single chain variable fragments (scFvs), that bind to two epitopes on the same target activate the receptor. The intracellular receptor domain can be chosen from several signal transduction domains of single-pass transmembrane receptors to activate endogenous signaling pathways. As of now, GEMS have been used for sensing prostate specific antigen (PSA), the synthetic azo dye RR120, caffeine, nicotine, rapamycin, the SunTag peptide, and a de novo designed protein displaying two viral epitopes. The tested intracellular domains were derived from FGFR1, IL-6RB, and VEGFR2, and were used to drive transgene expression from reporter plasmids responsive to the endogenous transcription factors STAT3, NFAT, NF-κB, and a synthetic transcription factor activated by the MAPK pathway. In this protocol, I focus on transient transfections of HEK293T cells and include several general notes about cell handling. While the described methods are optimized for experiments with GEMS, most of the described techniques are general procedures to set up synthetic biology experiments in mammalian cell culture. I outline how to generate stable cell lines and share tips on how to adapt GEMS for new ligands. The main objective of this protocol is to make the GEMS technology accessible also to nonspecialist laboratories to facilitate the use of synthetic receptors in new research contexts.

Entities:  

Keywords:  Bioengineering; Biotechnology; Cell therapy; Engineered cells; Mammalian synthetic biology; Protein engineering; Signal transduction; Synthetic biology; Synthetic receptors

Year:  2021        PMID: 34228282     DOI: 10.1007/978-1-0716-1441-9_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  [Case of diabetes insipidus with thyroxine binding globulin deficiency].

Authors:  H Maesaka; K Fukazawa; S Suwa; A Goto
Journal:  Horumon To Rinsho       Date:  1978-11

2.  Generalized extracellular molecule sensor platform for programming cellular behavior.

Authors:  Leo Scheller; Tobias Strittmatter; David Fuchs; Daniel Bojar; Martin Fussenegger
Journal:  Nat Chem Biol       Date:  2018-04-23       Impact factor: 15.040

3.  Rewiring human cellular input-output using modular extracellular sensors.

Authors:  Kelly A Schwarz; Nichole M Daringer; Taylor B Dolberg; Joshua N Leonard
Journal:  Nat Chem Biol       Date:  2016-12-12       Impact factor: 15.040

Review 4.  The Principles of Engineering Immune Cells to Treat Cancer.

Authors:  Wendell A Lim; Carl H June
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 5.  From synthetic biology to human therapy: engineered mammalian cells.

Authors:  Leo Scheller; Martin Fussenegger
Journal:  Curr Opin Biotechnol       Date:  2019-03-30       Impact factor: 10.279

6.  ANARCI: antigen receptor numbering and receptor classification.

Authors:  James Dunbar; Charlotte M Deane
Journal:  Bioinformatics       Date:  2015-09-30       Impact factor: 6.937

7.  Caffeine-inducible gene switches controlling experimental diabetes.

Authors:  Daniel Bojar; Leo Scheller; Ghislaine Charpin-El Hamri; Mingqi Xie; Martin Fussenegger
Journal:  Nat Commun       Date:  2018-06-19       Impact factor: 14.919

8.  A highly soluble Sleeping Beauty transposase improves control of gene insertion.

Authors:  Irma Querques; Andreas Mades; Cecilia Zuliani; Csaba Miskey; Miriam Alb; Esther Grueso; Markus Machwirth; Tobias Rausch; Hermann Einsele; Zoltán Ivics; Michael Hudecek; Orsolya Barabas
Journal:  Nat Biotechnol       Date:  2019-11-04       Impact factor: 68.164

9.  Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming.

Authors:  Krzysztof Krawczyk; Leo Scheller; Hyojin Kim; Martin Fussenegger
Journal:  Nat Commun       Date:  2020-01-30       Impact factor: 14.919

10.  Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors.

Authors:  Leonardo Morsut; Kole T Roybal; Xin Xiong; Russell M Gordley; Scott M Coyle; Matthew Thomson; Wendell A Lim
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.